Stay updated on Miransertib in Overgrowth Spectrum Clinical Trial
Sign up to get notified when there's something new on the Miransertib in Overgrowth Spectrum Clinical Trial page.

Latest updates to the Miransertib in Overgrowth Spectrum Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.5.2 was applied, replacing v3.5.0.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision number updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision label on the page was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2, indicating an administrative update to the page's revision history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page now displays Revision: v3.4.1 and no longer shows Revision: v3.4.0, a minor metadata update that does not affect study details or functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page now includes a Show glossary option. The labels for QC criteria submission and No FEAR Act data have been updated, and the revision identifier was raised to v3.4.0 from v3.3.4.SummaryDifference0.2%

Stay in the know with updates to Miransertib in Overgrowth Spectrum Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Miransertib in Overgrowth Spectrum Clinical Trial page.